Transition to dolutegravir is associated with an increase in the rate of BMI change in a cohort of virally suppressed adolescents
Clicks: 122
ID: 261478
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
122 views
42 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #653 of 1,084 articles by views in clinical infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
AbstractBackground. Antiretroviral therapy (ART) regimens that contain Dolutegravir (DTG) have been associated with increases in body mass index (BMI) in adult
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (21 words).
Try re-searching for a better abstract.
| Reference Key |
neilclinicaltransition
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Thivalapill, Neil;Simelane, Tandzile;Mthethwa, Nobuhle;Dlamini, Sandile;Lukhele, Bhekumusa;Okello, Velephi;Kirchner, H Lester;Mandalakas, Anna M;Kay, Alexander W; |
| Journal | clinical infectious diseases |
| Year | Year not found |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.